Call for papers: Emerging agents and regimens for cancer therapy
We are pleased to announce a new Journal of Hematology & Oncology thematic review series on "Emerging agents and regimens for cancer therapy." Reviews on novel agents, first-in-human studies, and regimens for different cancer types are welcome. Interested authors should submit a proposal to the editorial office at firstname.lastname@example.org as early as possible.
Image: © alvarez / Getty Images / iStock
Aims and scope
Journal of Hematology & Oncology is an open access, peer-reviewed online journal that encompasses all aspects of hematology and oncology. Read more.
"Journal of Hematology & Oncology provides a forum for top-quality research and is a leading title in hematology and oncology, with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an open access format among laboratory scientists, physician scientists, hematologists and oncologists."
Prof Delong Liu, Editor-in-Chief, Journal of Hematology & Oncology
Experimental Hematology & Oncology
Submit your research to our companion journal, Experimental Hematology & Oncology
Official journal of
Journal of Hematology & Oncology is the official journal of the Chinese American Hematologist and Oncologist Network.
- Editorial Board
- Sign up for article alerts and news from this journal
Annual Journal Metrics
37 days to first decision for reviewed manuscripts only
41 days to first decision for all manuscripts
79 days from submission to acceptance
15 days from acceptance to publication
7.333 - 2-year Impact Factor
6.457 - 5-year Impact Factor
1.316 - Source Normalized Impact per Paper (SNIP)
2.292 - SCImago Journal Rank (SJR)
376 Altmetric mentions